NPI Lens

Sudhir Bansal, MD

NPI 1356373633ActiveIndividual· Internal Medicine, Endocrinology, Diabetes & Metabolism· Warwick, RI

Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Warwick, Rhode Island, licensed in RI, with an NPI issued in July 2006. Part D covered 44 prescriptions written in 2024, 82% of them generic. Novartis Pharmaceuticals Corporation was the largest of 4 companies reporting payments in 2025, $403.00 in all, mostly food and beverage.

Overview

NPI1356373633
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorNo
NPI issuedJul 7, 2006
Last updated in NPPESJul 8, 2007

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Endocrinology, Diabetes & Metabolism Primary207RE0101X7603RI

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Internal Medicine (RI)

Part D prescriptions in 2024

Prescriptions (claims)44 · 112 30-day fills
Total drug cost$6,192
Generic share82% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$403.00 · 7 payments from 4 companies
  • 2024$124.86 · 3 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Novartis Pharmaceuticals Corporation$156.442
Novo Nordisk Inc$106.802
Alexion Pharmaceuticals, Inc.$84.221
Amgen Inc.$55.542

What the 2025 payments were for

  • Food and Beverage$403.00 · 7 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other endocrinologists in Warwick

All endocrinologists in Rhode Island